GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The zones of discrimination for M-Score is as such:
An M-Score of less than -2.22 suggests that the company is not an accounting manipulator.
An M-Score of greater than -2.22 signals that the company is likely an accounting manipulator.
Synageva BioPharma Corp has a M-score of -3.22 suggests that the company is not a manipulator.
During the past 13 years, the highest Beneish M-Score of Synageva BioPharma Corp was 22.18. The lowest was -6.46. And the median was -3.22.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Z-Score) or business trend (F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Synageva BioPharma Corp for today is based on a combination of the following eight different indices:
|M||=||-4.84||+||0.92 * DSRI||+||0.528 * GMI||+||0.404 * AQI||+||0.892 * SGI||+||0.115 * DEPI|
|=||-4.84||+||0.92 * 0.5907||+||0.528 * 1||+||0.404 * 0.5383||+||0.892 * 0.8943||+||0.115 * 2.1105|
|-||0.172 * SGAI||+||4.679 * TATA||-||0.327 * LVGI|
|-||0.172 * 1.7714||+||4.679 * -0.046||-||0.327 * 0.578|
|This Year (Dec13) TTM:||Last Year (Dec12) TTM:|
|Accounts Receivable was $1.37 Mil.|
Revenue was 3.474 + 1.369 + 3.413 + 5.118 = $13.37 Mil.
Gross Profit was 3.474 + 1.369 + 3.413 + 5.118 = $13.37 Mil.
Total Current Assets was $416.72 Mil.
Total Assets was $447.95 Mil.
Property, Plant and Equipment(Net PPE) was $17.21 Mil.
Depreciation, Depletion and Amortization(DDA) was $5.57 Mil.
Selling, General & Admin. Expense(SGA) was $27.56 Mil.
Total Current Liabilities was $13.92 Mil.
Long-Term Debt was $0.00 Mil.
Net Income was -30.736 + -28.123 + -22.107 + -14.484 = $-95.45 Mil.
Non Operating Income was 0.159 + 0 + 0 + 0 = $0.16 Mil.
Cash Flow from Operations was -26.395 + -15.453 + -16.003 + -17.151 = $-75.00 Mil.
|Accounts Receivable was $2.60 Mil.
Revenue was 4.88 + 5.428 + 2.249 + 2.397 = $14.95 Mil.
Gross Profit was 4.88 + 5.428 + 2.249 + 2.397 = $14.95 Mil.
Total Current Assets was $225.11 Mil.
Total Assets was $243.26 Mil.
Property, Plant and Equipment(Net PPE) was $4.01 Mil.
Depreciation, Depletion and Amortization(DDA) was $4.27 Mil.
Selling, General & Admin. Expense(SGA) was $17.40 Mil.
Total Current Liabilities was $13.08 Mil.
Long-Term Debt was $0.00 Mil.
1. DSRI = Days Sales in Receivables Index
A large increase in DSR could be indicative of revenue inflation.
|DSRI||=||(Receivables_t / Revenue_t)||/||(Receivables_t-1 / Revenue_t-1)|
|=||(1.373 / 13.374)||/||(2.599 / 14.954)|
2. GMI = Gross Margin Index
Measured as the ratio of gross margin in year t-1 to gross margin in year t.
Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.
|=||(GrossProfit_t-1 / Revenue_t-1)||/||(GrossProfit_t / Revenue_t)|
|=||(1.369 / 14.954)||/||(3.474 / 13.374)|
3. AQI = Asset Quality Index
AQI is the ratio of asset quality in year t to year t-1.
|AQI||=||(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)||/||(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)|
|=||(1 - (416.723 + 17.213) / 447.949)||/||(1 - (225.107 + 4.012) / 243.256)|
4. SGI = Sales Growth Index
Ratio of sales in year t to sales in year t-1.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
5. DEPI = Depreciation Index
Measured as the ratio of the rate of depreciation in year t-1 to the corresponding rate in year t.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
|DEPI||=||(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))||/||(Depreciation_t / (Depreciaton_t + PPE_t))|
|=||(4.272 / (4.272 + 4.012))||/||(5.566 / (5.566 + 17.213))|
6. SGAI = Sales, General and Administrative expenses Index
The ratio of SGA expenses in year t relative to year t-1.
SGA expenses index > 1 means that the company is becoming less efficient in generate sales.
|SGAI||=||(SGA_t / Sales_t)||/||(SGA_t-1 /Sales_t-1)|
|=||(27.56 / 13.374)||/||(17.396 / 14.954)|
7. LVGI = Leverage Index
The ratio of total debt to total assets in year t relative to yeat t-1.
An LVGI > 1 indicates an increase$sgai= in leverage
|LVGI||=||((LTD_t + CurrentLiabilities_t) / TotalAssets_t)||/||((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)|
|=||((0 + 13.92) / 447.949)||/||((0 + 13.079) / 243.256)|
8. TATA = Total Accruals to Total Assets
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
|=||(NetIncome_t - NonOperatingIncome_t||-||CashFlowsfromOperations_t)||/||TotalAssets_t|
|=||(-95.45 - 0.159||-||-75.002)||/||447.949|
An M-Score of less than -2.22 suggests that the company will not be a manipulator. An M-Score of greater than -2.22 signals that the company is likely to be a manipulator.
Synageva BioPharma Corp has a M-score of -3.22 suggests that the company will not be a manipulator.
Altman Z-Score, Piotroski F-Score, Accounts Receivable, Revenue, Gross Profit, Total Current Assets, Total Assets, Property, Plant and Equipment, Depreciation, Depletion and Amortization, Selling, General & Admin. Expense, Total Current Liabilities, Long-Term Debt, Net Income, Non Operating Income, Cash Flow from Operations
Synageva BioPharma Corp Annual Data
Synageva BioPharma Corp Quarterly Data